Tzyh-Chang Hwang, Ph.D., University of Missouri School of Medicine (IMAGE)
Caption
MU scientist Tzyh-Chang Hwang, Ph.D., and colleagues have redefined a key regulatory process in the defective protein responsible for cystic fibrosis, which could change treatment for patients with the lethal genetic disease. Described in the current issue of the Proceedings of the National Academy of Sciences, Hwang's research could reveal a way to improve the effectiveness of the first drug that targets the underlying cause of cystic fibrosis.
Credit
University of Missouri School of Medicine
Usage Restrictions
None
License
Licensed content